GE HealthCare Files 8-K
Ticker: GEHC · Form: 8-K · Filed: Nov 21, 2024 · CIK: 1932393
| Field | Detail |
|---|---|
| Company | Ge Healthcare Technologies Inc. (GEHC) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulation-fd, financial-statements, filing
Related Tickers: GEHC
TL;DR
GE HealthCare filed a standard 8-K, no major news.
AI Summary
GE HealthCare Technologies Inc. filed an 8-K on November 21, 2024, to report information under Regulation FD and to file financial statements and exhibits. The filing does not disclose specific new financial figures or material events beyond routine reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by GE HealthCare Technologies Inc., without immediate news of significant events or financial changes.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for Regulation FD disclosure and financial statements, not indicating any new risks or material changes.
Key Players & Entities
- GE HealthCare Technologies Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 001-41528 (file_number) — SEC File Number
- 88-2515116 (irs_number) — IRS Employer Identification No.
- 500 W. Monroe Street, Chicago, IL 60661 (address) — Principal executive offices
- ( 833 ) 735-1139 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for GE HealthCare Technologies Inc.?
The primary purpose is to report information under Regulation FD Disclosure and to file Financial Statements and Exhibits.
On what date was this 8-K report filed?
The report was filed on November 21, 2024.
In which U.S. state is GE HealthCare Technologies Inc. incorporated?
GE HealthCare Technologies Inc. is incorporated in Delaware.
What is the principal executive office address for GE HealthCare Technologies Inc.?
The principal executive office is located at 500 W. Monroe Street, Chicago, IL 60661.
Does this filing indicate any specific new financial results or material events?
No, this filing is a routine 8-K for Regulation FD and financial statements/exhibits, and does not specify new financial results or material events.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-11-21 06:05:20
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Marke
Filing Documents
- gehc-20241121.htm (8-K) — 29KB
- releaseinvestorday2024.htm (EX-99) — 35KB
- ge-hlthcr_newstandardxrgbxa.jpg (GRAPHIC) — 808KB
- gehealthcarelogonewmarch20a.jpg (GRAPHIC) — 180KB
- 0001932393-24-000054.txt ( ) — 1362KB
- gehc-20241121.xsd (EX-101.SCH) — 2KB
- gehc-20241121_lab.xml (EX-101.LAB) — 21KB
- gehc-20241121_pre.xml (EX-101.PRE) — 12KB
- gehc-20241121_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On November 21, 2024, GE HealthCare Technologies Inc. ("we" or "GE HealthCare") issued a press release in connection with our previously announced 2024 Investor Day. A copy of the press release is furnished as Exhibit 99 to this Current Report on Form 8-K. The information furnished pursuant to Item 7.01, including Exhibit 99, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99 Press release of GE HealthCare Technologies Inc., dated November 21, 2024. 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GE HealthCare Technologies Inc. (Registrant) Date: November 21, 2024 /s/ Frank R. Jimenez Frank R. Jimenez, General Counsel and Corporate Secretary (authorized signatory)